NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 5.57% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 5.07% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.45% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.39% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.36% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.86% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.77% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.76% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 3.76% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.69% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.67% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.60% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.59% |
| CNTA | Centessa Pharmaceuticals PLC ADR | Healthcare | Biotechnology | 3.49% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.40% |